Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment
MODERN PATHOLOGY
Authors: Friedman, Kenneth; Brodsky, Alexander S.; Lu, Shaolei; Wood, Stephanie; Gill, Anthony J.; Lombardo, Kara; Yang, Dongfang; Resnick, Murray B.
Abstract
Medullary carcinoma of the colon is a unique histologic subtype of microsatellite unstable colorectal carcinoma but little is known regarding its tumor-immunoregulatory microenvironment. The aims of this study were to characterize the immune environment of medullary carcinoma and compare it with other microsatellite unstable and microsatellite stable colorectal carcinomas. An initial gene expression microarray analysis of six cases of medullary carcinoma was used to detect potentially differentially expressed genes. We extended this analysis utilizing genomic data from the Cancer Genome Atlas to compare eight cases of medullary carcinoma with other microsatellite unstable and stable carcinomas. Finally, we evaluated expression of key immune pathway proteins and lymphocyte subsets via immunohistochemistry of a large group of medullary carcinomas (n=105) and compared these findings with three other groups: poorly differentiated, microsatellite unstable well-differentiated and microsatellite stable well-differentiated carcinomas. Microarray and the Cancer Genome Atlas data analysis identified significant upregulation of several immunoregulatory genes induced by IFN gamma including IDO-1, WARS (tRNA(trp)), GBP1, GBP4, GBP5, PDCD1 (PD-1), and CD274 (PD-L1) in medullary carcinoma compared with other microsatellite unstable and microsatellite stable tumors. By immunohistochemistry, IDO-1 was expressed in 64% of medullary carcinomas compared with 19% (9/47) of poorly differentiated carcinomas, 14% (3/22) of microsatellite unstable, and 7% (2/30) of the microsatellite stable well-differentiated carcinomas (P<0.0001). tRNA(trp) was overexpressed in 81% (84/104) of medullary carcinomas, 19% (9/47) of poorly differentiated, 32% (7/22) of microsatellite unstable, and 3% (1/30) of microsatellite stable well-differentiated carcinomas (P<0.0001). Medullary carcinoma had higher mean CD8+ and PD-L1+ tumor-infiltrating lymphocytes compared with all other groups (P<0.0001). This study demonstrates overexpression of several immunoregulatory genes in microsatellite unstable colorectal carcinomas and that expression of these genes and proteins is more prevalent in the medullary carcinoma subtype, which may be of use both diagnostically and therapeutically.
The putative monomeric G-protein GBP1 is negatively associated with fumonisin B-1 production in Fusarium verticillioides
MOLECULAR PLANT PATHOLOGY
Authors: Sagaram, Uma Shankar; Butchko, Robert A. E.; Shim, Won-Bo
Abstract
Fumonisin B-1 (FB1) is a mycotoxin produced by Fusarium verticillioides that contaminates maize. FB1 has been linked to a number of human and animal mycotoxicoses worldwide. Despite its significance, our understanding of the FB1 biosynthesis regulatory mechanisms is limited. Here, we describe F. verticillioides GBP1, encoding a monomeric G-protein, and its role in FB1 biosynthesis. GBP1 was discovered as an expressed sequence tag (EST) up-regulated in the F. verticillioides fcc1 mutant that showed reduced conidiation and no FB1 biosynthesis when grown on maize kernels. Sequence analysis showed that GBP1 encodes a putative 368-amino-acid protein with similarity to DRG and Obg subclasses of G-proteins that are involved in development and stress responses. A GBP1 knockout mutant (Delta gbp1) exhibited normal growth, but increased FB1 production (> 58%) compared with the wild-type when grown on corn kernels. Complementation of Delta gbp1 with the wild-type GBP1 gene restored FB1 production levels to that of the wild-type. Our data indicate that GBP1 is negatively associated with FB1 biosynthesis but not with conidiation in F. verticillioides. The deletion of GBP1 led to up-regulation of key FB1 biosynthetic genes, FUM1 and FUM8, suggesting that the increased FB1 production in Delta gbp1 is due to over-expression of FUM genes.